217 related articles for article (PubMed ID: 8760601)
1. Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination.
Yashiro M; Chung YS; Inoue T; Nishimura S; Matsuoka T; Fujihara T; Sowa M
Int J Cancer; 1996 Jul; 67(2):289-93. PubMed ID: 8760601
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis.
Na D; Lv ZD; Liu FN; Xu Y; Jiang CG; Sun Z; Miao ZF; Li F; Xu HM
Int J Mol Med; 2010 Sep; 26(3):325-32. PubMed ID: 20664947
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.
Panos RJ; Rubin JS; Csaky KG; Aaronson SA; Mason RJ
J Clin Invest; 1993 Aug; 92(2):969-77. PubMed ID: 7688769
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells.
Rampino T; Cancarini G; Gregorini M; Guallini P; Maggio M; Ranghino A; Soccio G; Dal Canton A
Am J Pathol; 2001 Oct; 159(4):1275-85. PubMed ID: 11583955
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 produced by gastric cancer cells affects mesothelial cell morphology in peritoneal dissemination.
Nishimura S; Hirakawa-Chung KY; Yashiro M; Inoue T; Matsuoka T; Fujihara T; Murahashi K; Sawada T; Nakata B; Jikihara I; Takagi H; Sowa M
Int J Oncol; 1998 Apr; 12(4):847-51. PubMed ID: 9499445
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.
Inoue T; Chung YS; Yashiro M; Nishimura S; Hasuma T; Otani S; Sowa M
Jpn J Cancer Res; 1997 Feb; 88(2):152-9. PubMed ID: 9119743
[TBL] [Abstract][Full Text] [Related]
8. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.
Lv ZD; Wang HB; Dong Q; Kong B; Li JG; Yang ZC; Qu HL; Cao WH; Xu HM
Mol Cell Biochem; 2013 May; 377(1-2):177-85. PubMed ID: 23392771
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
[TBL] [Abstract][Full Text] [Related]
10. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways.
Warn R; Harvey P; Warn A; Foley-Comer A; Heldin P; Versnel M; Arakaki N; Daikuhara Y; Laurent GJ; Herrick SE; Mutsaers SE
Exp Cell Res; 2001 Jul; 267(2):258-66. PubMed ID: 11426944
[TBL] [Abstract][Full Text] [Related]
11. Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum.
Ono YJ; Hayashi M; Tanabe A; Hayashi A; Kanemura M; Terai Y; Ohmichi M
Am J Physiol Endocrinol Metab; 2015 Jun; 308(11):E950-9. PubMed ID: 25852006
[TBL] [Abstract][Full Text] [Related]
12. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors.
Seslar SP; Nakamura T; Byers SW
Cancer Res; 1993 Mar; 53(6):1233-8. PubMed ID: 8443802
[TBL] [Abstract][Full Text] [Related]
13. Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.
Lv ZD; Zhao WJ; Jin LY; Wang WJ; Dong Q; Li N; Xu HM; Wang HB
Biomed Pharmacother; 2017 Apr; 88():27-33. PubMed ID: 28092842
[TBL] [Abstract][Full Text] [Related]
14. CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells.
Nishimura S; Chung YS; Yashiro M; Inoue T; Sowa M
Jpn J Cancer Res; 1996 Dec; 87(12):1235-44. PubMed ID: 9045958
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel.
Saed GM; Kruger M; Diamond MP
Wound Repair Regen; 2004; 12(5):557-64. PubMed ID: 15453838
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression.
Kanaji N; Yokohira M; Nakano-Narusawa Y; Watanabe N; Imaida K; Kadowaki N; Bandoh S
Respir Res; 2017 Jun; 18(1):118. PubMed ID: 28619066
[TBL] [Abstract][Full Text] [Related]
18. Estrogen mediates mammary epithelial cell proliferation in serum-free culture indirectly via mammary stroma-derived hepatocyte growth factor.
Zhang HZ; Bennett JM; Smith KT; Sunil N; Haslam SZ
Endocrinology; 2002 Sep; 143(9):3427-34. PubMed ID: 12193555
[TBL] [Abstract][Full Text] [Related]
19. Possible role of hepatocyte growth factor in regeneration of human peritoneal mesothelial cells.
Naiki Y; Matsuo K; Matsuoka T; Maeda Y
Int J Artif Organs; 2005 Feb; 28(2):141-9. PubMed ID: 15770602
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
